222 related articles for article (PubMed ID: 21132637)
21. Kaposi's sarcoma following immunosuppressive therapy for vasculitis.
Bouattar T; Kazmouhi L; Alhamany Z; Beqqal K; Haffane L; Houssaini TS; Rhou H; Benamar L; Senouci K; Bayahia R; Ouzeddoun N
Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):319-23. PubMed ID: 21422634
[TBL] [Abstract][Full Text] [Related]
22. Rituximab treatment for vasculitis.
Jayne D
Clin J Am Soc Nephrol; 2010 Aug; 5(8):1359-62. PubMed ID: 20671223
[No Abstract] [Full Text] [Related]
23. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic effect and clinical findings in patients with MPO-ANCA associated vasculitis syndrome].
Yoshida A; Takeda A; Fukuda M; Toda S; Morozumi K
Ryumachi; 2000 Feb; 40(1):1-8. PubMed ID: 10783659
[TBL] [Abstract][Full Text] [Related]
25. Rituximab in ANCA-associated disease.
Falk RJ; Jennette JC
N Engl J Med; 2010 Jul; 363(3):285-6. PubMed ID: 20647204
[No Abstract] [Full Text] [Related]
26. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome.
Jabur WL; Saeed HM
Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883
[TBL] [Abstract][Full Text] [Related]
27. Outcome of renal transplantation in patients with both ANCA and anti-GBM antibodies.
Raman G; Srivastava A; Geetha D
Transplantation; 2012 Sep; 94(5):e30-1. PubMed ID: 22955170
[No Abstract] [Full Text] [Related]
28. Autoantibodies in ANCA-associated vasculitis.
Wiik AS
Rheum Dis Clin North Am; 2010 Aug; 36(3):479-89. PubMed ID: 20688245
[TBL] [Abstract][Full Text] [Related]
29. [ANCA-associated vasculitis].
Sinico RA; Sabadini E; Boeri R; Radice A
G Ital Nefrol; 2002; 19(2):125-36. PubMed ID: 12195410
[TBL] [Abstract][Full Text] [Related]
30. Itraconazole as a novel addition to ANCA-associated vasculitides or other neutrophilic dermatosis armamentarium.
Pazyar N; Feily A
Minerva Med; 2010 Dec; 101(6):458-9. PubMed ID: 21196906
[No Abstract] [Full Text] [Related]
31. Adverse effects of therapy for ANCA-associated vasculitis.
Turnbull J; Harper L
Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):391-401. PubMed ID: 19508946
[TBL] [Abstract][Full Text] [Related]
32. Maintenance treatment of ANCA-associated vasculitides.
Guillevin L
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):199-201. PubMed ID: 28406765
[TBL] [Abstract][Full Text] [Related]
33. Ocular manifestations of ANCA-associated vasculitis.
Kubal AA; Perez VL
Rheum Dis Clin North Am; 2010 Aug; 36(3):573-86. PubMed ID: 20688251
[TBL] [Abstract][Full Text] [Related]
34. [ANCA-vasculitis with renal impairment treated by intravenous versus oral cyclophosphamide: Multicentric analysis of relapse free survival (VaReCyS)].
Gouin JB; Dhalluin T; Perrichot R; Vigneau C; Michel A
Nephrol Ther; 2020 Jul; 16(4):201-210. PubMed ID: 32653427
[TBL] [Abstract][Full Text] [Related]
35. MPO-ANCA-associated pulmonary-renal vasculitis in a patient with diabetes mellitus.
Keven K; Akar H; Kutlay S; Nergizoglu G; Erbay B; Erturk S
J Nephrol; 2002; 15(6):720-3. PubMed ID: 12495292
[TBL] [Abstract][Full Text] [Related]
36. Atypical clinical course of antineutrophil cytoplasmic autoantibodies-associated vasculitis.
Tayebi Khosroshahi H; Etemadi J; Fakhrju A; Pishahang E; Rezaii M
Iran J Kidney Dis; 2013 Jul; 7(4):319-22. PubMed ID: 23880811
[TBL] [Abstract][Full Text] [Related]
37. Systemic vasculitis associated with anti-neutrophil cytoplasmic antibodies against bactericidal/permeability increasing protein.
Fukuhara A; Tanino Y; Sato S; Ishii T; Nikaido T; Kanazawa K; Saito J; Ishida T; Kanno M; Watanabe T; Munakata M
Intern Med; 2013; 52(10):1095-9. PubMed ID: 23676597
[TBL] [Abstract][Full Text] [Related]
38. [Diffuse pulmonary hemorrhage associated with antineutrophil cytoplasmic antibodies. Findings of high-resolution computerized tomography. A case report].
Galeotti R; Sala S; Rosina G; Mannella P
Radiol Med; 1997 Dec; 94(6):685-7. PubMed ID: 9524614
[No Abstract] [Full Text] [Related]
39. ANCA renal risk score predicts outcome in the Manchester cohort.
Li AS; Saleh C; Denley H; Patel M; Brix SR
Kidney Int; 2019 Jul; 96(1):246-247. PubMed ID: 31229033
[No Abstract] [Full Text] [Related]
40. Anti-neutrophil cytoplasmic antibody (ANCA) associated small-vessel vasculitis in a patient with diabetic nephropathy and autoimmune polyendocrinopathy syndrome (APS) Type 2: a case report.
Murray JS; Baines LA; Pearce SH; Ball S; Leech N; Wood KM; Kanagasundaram NS
Clin Nephrol; 2013 Sep; 80(3):223-6. PubMed ID: 22541677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
